Date Filed | Type | Description |
03/17/2021 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 99 shares
@ $16.22, valued at
$1.6k
Granted 99 options to buy
@ $19.08, valued at
$1.9k
|
|
03/02/2021 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 90 shares
@ $17.89, valued at
$1.6k
Granted 90 options to buy
@ $21.05, valued at
$1.9k
|
|
02/17/2021 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 76 shares
@ $21.19, valued at
$1.6k
Granted 76 options to buy
@ $24.93, valued at
$1.9k
|
|
02/02/2021 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 82 shares
@ $19.64, valued at
$1.6k
Granted 82 options to buy
@ $23.11, valued at
$1.9k
|
|
01/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 121 shares
@ $12.91, valued at
$1.6k
Granted 121 options to buy
@ $15.19, valued at
$1.8k
|
|
12/10/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 60,373 options to buy
@ $16.52, valued at
$997.4k
|
|
12/02/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 122 shares
@ $12.77, valued at
$1.6k
Granted 122 options to buy
@ $15.02, valued at
$1.8k
|
|
11/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 128 shares
@ $12.2, valued at
$1.6k
Granted 128 options to buy
@ $14.35, valued at
$1.8k
|
|
11/03/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 127 shares
@ $12.25, valued at
$1.6k
Granted 127 options to buy
@ $14.41, valued at
$1.8k
|
|
10/19/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 117 shares
@ $13.35, valued at
$1.6k
Granted 117 options to buy
@ $15.7, valued at
$1.8k
|
|
09/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 72 shares
@ $13.06, valued at
$940.3 Granted 72 options to buy
@ $15.37, valued at
$1.1k
|
|
09/02/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 69 shares
@ $13.73, valued at
$947.4 Granted 69 options to buy
@ $16.15, valued at
$1.1k
|
|
08/18/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 31 shares
@ $30.71, valued at
$952 Granted 31 options to buy
@ $36.13, valued at
$1.1k
|
|
08/04/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 30 shares
@ $30.91, valued at
$927.3 Granted 30 options to buy
@ $36.37, valued at
$1.1k
|
|
07/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 27 shares
@ $34.21, valued at
$923.7 Granted 27 options to buy
@ $40.25, valued at
$1.1k
|
|
06/02/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 34 shares
@ $27.77, valued at
$944.2 Granted 34 options to buy
@ $32.67, valued at
$1.1k
|
|
05/19/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 39 shares
@ $24, valued at
$936 Granted 39 options to buy
@ $28.24, valued at
$1.1k
|
|
05/04/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 39 shares
@ $23.93, valued at
$933.3 Granted 39 options to buy
@ $28.15, valued at
$1.1k
|
|
04/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 41 shares
@ $22.82, valued at
$935.6 Granted 41 options to buy
@ $26.85, valued at
$1.1k
|
|
04/02/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 40 shares
@ $23.47, valued at
$938.8 Granted 40 options to buy
@ $27.61, valued at
$1.1k
|
|
03/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 48 shares
@ $19.59, valued at
$940.3 Granted 48 options to buy
@ $23.05, valued at
$1.1k
|
|
03/03/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 37 shares
@ $25.15, valued at
$930.6 Granted 37 options to buy
@ $29.59, valued at
$1.1k
|
|
02/19/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 35 shares
@ $26.73, valued at
$935.6 Granted 35 options to buy
@ $31.45, valued at
$1.1k
|
|
02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/17/2020 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 40 shares
@ $23.15, valued at
$926 Granted 40 options to buy
@ $27.23, valued at
$1.1k
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2019 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 37 shares
@ $24.62, valued at
$910.9 Granted 37 options to buy
@ $28.97, valued at
$1.1k
|
|
12/12/2019 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 57,198 options to buy
@ $30.51, valued at
$1.7M
|
|
12/03/2019 |
4
| O'Connell Joseph P (Chief Medical Officer) has filed a Form 4 on Odonate Therapeutics, Inc.
Txns:
| Granted 31 shares
@ $29.22, valued at
$905.8 Granted 31 options to buy
@ $34.38, valued at
$1.1k
|
|
11/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|